1. Home
  2. CRSP vs BYD Comparison

CRSP vs BYD Comparison

Compare CRSP & BYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$50.20

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Logo Boyd Gaming Corporation

BYD

Boyd Gaming Corporation

HOLD

Current Price

$71.22

Market Cap

4.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
BYD
Founded
2013
1973
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.8B
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
CRSP
BYD
Price
$50.20
$71.22
Analyst Decision
Buy
Buy
Analyst Count
23
19
Target Price
$85.63
★ $93.94
AVG Volume (30 Days)
★ 1.5M
1.0M
Earning Date
11-09-2026
10-22-2026
Dividend Yield
N/A
★ 1.13%
EPS Growth
N/A
★ 264.46
EPS
N/A
★ 3.12
Revenue
$289,590,000.00
★ $2,626,730,000.00
Revenue This Year
$1,052.09
$0.04
Revenue Next Year
$273.88
$2.19
P/E Ratio
★ N/A
$22.54
Revenue Growth
★ 9169.85
9.41
52 Week Low
$44.12
$65.00
52 Week High
$70.74
$91.41

Technical Indicators

Market Signals
Indicator
CRSP
BYD
Relative Strength Index (RSI) 41.49 44.57
Support Level $45.61 $65.00
Resistance Level $60.71 $71.29
Average True Range (ATR) 2.51 1.61
MACD -0.48 0.58
Stochastic Oscillator 8.96 77.53

Price Performance

Historical Comparison
CRSP
BYD

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About BYD Boyd Gaming Corporation

Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. The Midwest and South hold the key number of entertainment properties and generate the majority of the company's revenue.

Share on Social Networks: